C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma.
about
RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediateEpstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistenceRecent insights in the pathogenesis of post-transplantation lymphoproliferative disordersBurkitt lymphoma: pathogenesis and immune evasion.Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsClinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma.Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphomaReconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis.c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.Acetaminophen modulates the transcriptional response to recombinant interferon-beta.Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression.Synergy of interleukin 10 and toll-like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis.Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic CellsN-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cellsDownregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.MYC: Master Regulator of Immune Privilege.Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families.Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.Cytokines associated with Burkitt's lymphoma in western Kenya.Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.Immunogenic effects of chemotherapy-induced tumor cell death
P2860
Q24315639-CFA53618-65B2-400C-A994-F766B1DB811BQ24648180-F00B2C5C-F01B-48C3-9CC0-1FF82DD6582BQ28075701-A4949DB0-A450-4E37-8A5A-F77A66AED69CQ34189497-45565FF6-3D9E-4220-8C34-034EC8742AECQ35071179-5322FF95-91BD-4E04-8A10-6C600416C77DQ36204839-81A525D1-FB4A-4511-9766-B315C61F2E9BQ36741637-6517DE3B-E256-4B83-9671-5C1FB8A80429Q36915248-E81C6F94-865A-422E-B479-CC89CD198EABQ37192244-221664A7-6638-417F-8020-FB3DD2336D06Q37833424-68E98B4C-18E9-41AD-95DC-4E29CA1E6F2AQ38506089-67D96BBA-C590-4E08-8A73-A06114178AD4Q38691995-3D553A1C-C816-4A97-8BDB-DCD1B6B86DA2Q38743752-45FBAE7E-F132-4F02-BE48-E0CDAD4AD20CQ38746231-68215AB6-7937-4202-A02B-CD47D1BC55CCQ38746434-B219818D-E735-4E96-BBCD-419849077387Q38770676-E83FDA46-610B-45CB-B59E-C157C8A18254Q39149130-6A6C0F97-2043-448E-B80B-508AA0DF3DBEQ39931378-CEBA1FF8-3EDA-4366-874B-9B4385BC70CAQ42264347-E085BAB5-4DC6-47AD-AAD8-73BE7440E27BQ47098487-3290AF44-7BED-4CBB-86B6-73D614E51ABDQ47368952-B6BFAF61-B322-4C1E-A473-D84D59A1B578Q50348505-BEA42144-DA21-48A3-895A-A3D8BD52FEC3Q57497508-09282D53-BFED-4295-921C-8E0AFF145562
P2860
C-myc activation impairs the NF-kappaB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
C-myc activation impairs the N ...... genesis of Burkitt's lymphoma.
@en
type
label
C-myc activation impairs the N ...... genesis of Burkitt's lymphoma.
@en
prefLabel
C-myc activation impairs the N ...... genesis of Burkitt's lymphoma.
@en
P2093
P2860
P50
P356
P1476
C-myc activation impairs the N ...... genesis of Burkitt's lymphoma.
@en
P2093
Andreas Rosenwald
Fanny Baran-Marszak
Gerhard Laux
Judith Reschke
Louis M Staudt
Marino Schuhmacher
Michael Hölzel
Reinhard Mailhammer
Remi Fagard
P2860
P304
P356
10.1002/IJC.22372
P577
2007-04-01T00:00:00Z